PROTECTIVE PROPERTIES OF THE VACCINE STRAIN 55-VNIIVVIM AND ACAPSULAR STRAIN BACILLUS ANTHRACIS 363/11

Objective of the work was to determine protective potential and safety for animals of the naturally attenuated B. anthracis 363/11 monoplazmid non-capsular strain to be used as a new candidate vaccine strain for the development and enhancement of specific prophylaxis of anthrax. Materials and method...

Full description

Bibliographic Details
Main Authors: T. A. Sevskikh, Yu. O. Selyaninov, I. Yu. Egorova
Format: Article
Language:Russian
Published: Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2017-06-01
Series:Проблемы особо опасных инфекций
Subjects:
Online Access:https://journal.microbe.ru/jour/article/view/399
_version_ 1797220823687233536
author T. A. Sevskikh
Yu. O. Selyaninov
I. Yu. Egorova
author_facet T. A. Sevskikh
Yu. O. Selyaninov
I. Yu. Egorova
author_sort T. A. Sevskikh
collection DOAJ
description Objective of the work was to determine protective potential and safety for animals of the naturally attenuated B. anthracis 363/11 monoplazmid non-capsular strain to be used as a new candidate vaccine strain for the development and enhancement of specific prophylaxis of anthrax. Materials and methods. Vaccine strain 55-VNIIVViM that is used for welfare provision as regards anthrax in animals in the territory of Russia was employed for the comparison of protective properties. Identification of LD50, ImD50 and protective efficacy was carried out using standard protocols for modeling the infection on laboratory (white mice, guinea pigs) and targeted (sheep) animals. Results and conclusions. It is established that avirulent for white mice B. anthracis 363/11 strain demonstrates higher protective and immunogenic activity than 55-VNIIVViM strain. It does not reverse to the virulent variant after passaging on the nutrient media and in the organism of susceptible animals. Thus it allows for considering B. anthracis 363/11 strain as a promising candidate vaccine strain, the utilization of which will improve epizootic situation on anthrax in the Russian Federation.
first_indexed 2024-03-08T13:42:36Z
format Article
id doaj.art-aaab1388281845caad3d461e1782c9ff
institution Directory Open Access Journal
issn 0370-1069
2658-719X
language Russian
last_indexed 2024-04-24T12:55:40Z
publishDate 2017-06-01
publisher Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe”
record_format Article
series Проблемы особо опасных инфекций
spelling doaj.art-aaab1388281845caad3d461e1782c9ff2024-04-05T16:47:12ZrusFederal Government Health Institution, Russian Research Anti-Plague Institute “Microbe”Проблемы особо опасных инфекций0370-10692658-719X2017-06-0102848610.21055/0370-1069-2017-2-84-86399PROTECTIVE PROPERTIES OF THE VACCINE STRAIN 55-VNIIVVIM AND ACAPSULAR STRAIN BACILLUS ANTHRACIS 363/11T. A. Sevskikh0Yu. O. Selyaninov1I. Yu. Egorova2National Research Institute of Veterinary Virology and Microbiology, Russian Academy of Agricultural ScienceNational Research Institute of Veterinary Virology and Microbiology, Russian Academy of Agricultural ScienceNational Research Institute of Veterinary Virology and Microbiology, Russian Academy of Agricultural ScienceObjective of the work was to determine protective potential and safety for animals of the naturally attenuated B. anthracis 363/11 monoplazmid non-capsular strain to be used as a new candidate vaccine strain for the development and enhancement of specific prophylaxis of anthrax. Materials and methods. Vaccine strain 55-VNIIVViM that is used for welfare provision as regards anthrax in animals in the territory of Russia was employed for the comparison of protective properties. Identification of LD50, ImD50 and protective efficacy was carried out using standard protocols for modeling the infection on laboratory (white mice, guinea pigs) and targeted (sheep) animals. Results and conclusions. It is established that avirulent for white mice B. anthracis 363/11 strain demonstrates higher protective and immunogenic activity than 55-VNIIVViM strain. It does not reverse to the virulent variant after passaging on the nutrient media and in the organism of susceptible animals. Thus it allows for considering B. anthracis 363/11 strain as a promising candidate vaccine strain, the utilization of which will improve epizootic situation on anthrax in the Russian Federation.https://journal.microbe.ru/jour/article/view/399b. anthracisimmunogenic activityprotectivitycandidate vaccine
spellingShingle T. A. Sevskikh
Yu. O. Selyaninov
I. Yu. Egorova
PROTECTIVE PROPERTIES OF THE VACCINE STRAIN 55-VNIIVVIM AND ACAPSULAR STRAIN BACILLUS ANTHRACIS 363/11
Проблемы особо опасных инфекций
b. anthracis
immunogenic activity
protectivity
candidate vaccine
title PROTECTIVE PROPERTIES OF THE VACCINE STRAIN 55-VNIIVVIM AND ACAPSULAR STRAIN BACILLUS ANTHRACIS 363/11
title_full PROTECTIVE PROPERTIES OF THE VACCINE STRAIN 55-VNIIVVIM AND ACAPSULAR STRAIN BACILLUS ANTHRACIS 363/11
title_fullStr PROTECTIVE PROPERTIES OF THE VACCINE STRAIN 55-VNIIVVIM AND ACAPSULAR STRAIN BACILLUS ANTHRACIS 363/11
title_full_unstemmed PROTECTIVE PROPERTIES OF THE VACCINE STRAIN 55-VNIIVVIM AND ACAPSULAR STRAIN BACILLUS ANTHRACIS 363/11
title_short PROTECTIVE PROPERTIES OF THE VACCINE STRAIN 55-VNIIVVIM AND ACAPSULAR STRAIN BACILLUS ANTHRACIS 363/11
title_sort protective properties of the vaccine strain 55 vniivvim and acapsular strain bacillus anthracis 363 11
topic b. anthracis
immunogenic activity
protectivity
candidate vaccine
url https://journal.microbe.ru/jour/article/view/399
work_keys_str_mv AT tasevskikh protectivepropertiesofthevaccinestrain55vniivvimandacapsularstrainbacillusanthracis36311
AT yuoselyaninov protectivepropertiesofthevaccinestrain55vniivvimandacapsularstrainbacillusanthracis36311
AT iyuegorova protectivepropertiesofthevaccinestrain55vniivvimandacapsularstrainbacillusanthracis36311